IP Library Granted Patent US 10,751,536
Granted Patent B1
US 10,751,536 · App. 15/870,052 · Granted Aug 25, 2020

Methods and systems for disease treatment using electrical stimulation

Inventors: Gary Heit (Woodside, CA); Bradford Evan Gliner (Sammamish, WA)
Assignee: Nevro Corp.
A61N1/36071A61N1/36157A61N1/36171A61N1/36175
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,751,536
App. No.
15/870,052
Granted
Aug 25, 2020
Kind
B1
Abstract

Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz.

Claims (26)

1. A method for treating a patient by changing an expression of a fast sodium channel of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a pulse width in a pulse width range of 10 microseconds to 333 microseconds;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population;

applying the electrical therapy signal to the target neural population, wherein the electrical therapy signal

produces changes in the expression of the fast sodium channel of the patient.

2. The method of claim 1 wherein the electrical therapy signal has a frequency in a frequency range of 1.5 kHz to 100 kHz.

3. The method of claim 1 wherein the target neural population is located in one or more of the patient's tissues.

4. The method of claim 1 wherein the target neural population is located in one or more of the patient's organs.

5. The method of claim 1 wherein the target neural population is at a peripheral nerve of the patient.

6. The method of claim 1 wherein the target neural population is located in the patient's central nervous system.

7. The method of claim 6 wherein the target neural population is at the patient's spinal cord.

8. The method of claim 7 wherein the target neural population is at a cervical vertebral level.

9. The method of claim 7 wherein the target neural population is at a thoracic vertebral level.

10. The method of claim 7 wherein the target neural population is at a lumbar vertebral level.

11. The method of claim 7 wherein the target neural population is at a sacral vertebral level.

12. The method of claim 7 wherein the target neural population is at a horsetail region.

13. The method of claim 1 wherein the changes include a downregulation of the expression of the fast sodium channel of the patient.

14. The method of claim 1 wherein the changes include a normalization of pathological neural networks associated with fast sodium channel expression.

15. The method of claim 1 wherein a frequency of the electrical therapy signal affects expression of NaV1.8, NaV1.9, or both NaV1.8 and NaV1.9 sodium channels over another, slower sodium channel.

16. The method of claim 1 , further comprising applying the therapy signal to increase expression of the slower sodium channel.

17. The method of claim 16 wherein the slower sodium channel includes a NaV1.3 channel.

18. The method of claim 1 wherein the changes include an increase in the expression of the fast sodium channel of the patient.

19. The method of claim 1 wherein the changes include a decrease in the expression of the fast sodium channel of the patient.

20. The method of claim 1 wherein the electrical therapy signal has an amplitude in an amplitude range of 0.1 mA to 20 mA.

21. The method of claim 1 wherein the electrical therapy signal has a duty cycle in a duty cycle range of 5% to 75%.

22. The method of claim 1 wherein the electrical signal has a pulse width in a pulse width range of 10 microseconds to 333 microseconds and an amplitude in an amplitude range of 0.1 mA to 20 mA.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2019
From: HEIT, GARY; GLINER, BRADFORD EVAN
To: NEVRO CORP.
Reel/Frame 048010/0094 →
Continuity (2)
Continuation 14300193 · Jun 9, 2014
Provisional Application 61833392 · Jun 10, 2013
Cited By (7)
US 12,280,256 US 12,408,974 US 12,415,074 US 12,447,333 US 12,478,806 US 12,539,167 US 12,661,516